Precision immunogenicity
for every patient.
From personalized cancer vaccines for patients to immunogenicity prediction for life sciences programs.
Personalized cancer immunotherapy,
designed for you.
Invoke Bio is developing investigational personalized cancer vaccines. We work with your physician and the FDA's Expanded Access (Compassionate Use) pathway to support access to our neoantigen vaccine program for eligible patients.
If you or your care team would like to learn more about our investigational program and whether it may be appropriate for your situation, we invite you to reach out. All inquiries are handled directly by our team.
Contact Us to Learn MoreOur cancer vaccines are investigational and have not been approved by the FDA for general use. Access is facilitated through the FDA's Expanded Access program under physician supervision.
Interested in learning more?
Whether you are a care team seeking information about our investigational program or a life sciences organization looking to collaborate, we want to hear from you.